Core Insights - The collaboration between Chengzhi Life and Beijing Sport University has successfully completed clinical exploration of D-Ribose for marathon athletes, demonstrating significant benefits for heart protection and athletic performance [1][2][4] - Chengzhi Co., as a leader in synthetic biology, has achieved a milestone in the industrial application of synthetic biology technology, contributing to global health industry transformation [1][2][10] Group 1: Clinical Research Findings - The study indicates that the Lipoz D-Ribose supplement significantly enhances heart protection, athletic performance, and fatigue recovery in marathon runners [2][5] - D-Ribose acts as a "cellular energy engine," directly participating in ATP synthesis and accelerating energy regeneration, which is crucial for endurance sports like marathons [5][6] - The clinical trials involved both middle-aged and young marathon runners, showing that D-Ribose supplementation reduces muscle damage and improves recovery speed [5][6] Group 2: Technological Advancements - Chengzhi Co. has developed a fermentation method for D-Ribose production, which is environmentally friendly and avoids toxic chemicals, achieving high purity and stability [7][10] - The company has established a comprehensive intellectual property network covering various aspects of D-Ribose production and application, positioning itself as a leader in the field [10][11] Group 3: Market Strategy and Achievements - Chengzhi Co. employs a "technology + market" dual-driven strategy, enhancing its global market presence through acquisitions and partnerships [10][11] - The company has seen a 50% increase in sales of Lipoz D-Ribose in 2024, with single product sales exceeding 100 million yuan, indicating strong market demand [11][12] - Chengzhi Co. has received multiple awards and recognitions, solidifying its position as a leading brand in the D-Ribose product category [11][12]

Core Viewpoint - The company is committed to implementing national strategies and focusing on high-quality development, with a strong emphasis on new productive forces and a diversified industrial system covering clean energy, semiconductor display materials, and life sciences [2] Group 1: Clean Energy - The subsidiary Nanjing Chengzhi is a leading operator in the domestic clean energy sector, specializing in the production and operation of industrial gases such as hydrogen, carbon monoxide, and synthesis gas [2] - The company also produces chemical products like methanol, ethylene, propylene, and butanol, leveraging the geographical advantages of the Qingdao Dongjiakou Chemical Park to extend its reach into the downstream new materials sector [2] - Continuous efforts are being made to adjust and upgrade the structure of the clean energy business [2] Group 2: Semiconductor Display Materials - The subsidiary Shijiazhuang Chengzhi Yonghua is the first domestic manufacturer to independently develop liquid crystal materials, with products spanning monochrome liquid crystal materials, TFT-LCD liquid crystal materials, and OLED materials [2] - The company is expanding from a focus on liquid crystal materials to broader display industry applications [2] Group 3: Life Sciences - The company is dedicated to research and development in high-tech products within the biotechnology sector, focusing on product innovation and market expansion [2] - Key products include D-ribose, D-mannose, and nutritional supplements like Libos [2]

Core Viewpoint - The company is focusing on the development of self-developed blue light materials for OLED, including both blue light host and guest materials, and has achieved mass production in some domestic sixth-generation OLED panel production lines [1] Group 1: OLED Materials - The company's R&D is primarily concentrated on self-developed blue light materials, which include blue light host and guest materials [1] - The company has achieved mass production in certain domestic sixth-generation OLED panel production lines [1] - The company is also exploring new directions in blue light materials, such as dual-EML and super fluorescent materials [1] Group 2: Photoresist Development - The company is currently in the experimental R&D stage for photoresist materials [1] - The company will continue to follow up on customer validation progress in this area [1] Group 3: Market Strategy - The company aims to seize opportunities in the domestic substitution of display materials [1] - The company plans to continuously strengthen R&D investment and market expansion [1] - The company is committed to promoting the upgrade of its product structure towards high-end products [1]

Core Viewpoint - The company is currently in the experimental research and development stage for its expansion into the photoresist materials sector and is actively following up on customer validation progress [1] Group 1 - The company has received inquiries from investors regarding its future development strategy, specifically about its expansion into the photoresist materials field [1] - As of January 7, the company confirmed its ongoing efforts in the experimental R&D phase [1] - The company is committed to continuously monitoring the progress of customer validation [1]

Core Viewpoint - The "15th Five-Year Plan" emphasizes the development of strategic emerging industries, including ultra-high molecular weight polyethylene (UHMWPE), which is becoming a focal point in the industry chain competition and is included in the 2024 national key R&D plan [1] Industry Overview - The UPE industry in China is experiencing rapid capacity expansion, with domestic UPE capacity expected to reach 731,100 tons by 2025, an increase of 32,700 tons within the year, representing a growth rate of 81% [2] - UPE is increasingly utilized in various strategic emerging industries, with the lithium battery separator becoming the largest application field, projected to demand 159,000 tons by 2025, accounting for 40.6% of total consumption [2] Future Growth Potential - UPE consumption in China is expected to reach 1,140,000 tons by 2030, with a compound annual growth rate of approximately 24% [3] - The demand for UPE is driven by increasing overseas market needs and domestic supply chain autonomy, particularly in the rapidly growing new energy vehicle and energy storage sectors [3] Market Positioning - The reliance on imports for high-end UPE products remains, with an average annual growth rate of 27% in UPE imports from 2016 to 2025 [4] - The launch of a 40,000 tons/year UPE project by Chengzhi Co. is a strategic response to the opportunity for domestic UPE production and aligns with national policies promoting technological self-reliance [4] Strategic Development - Chengzhi Co. aims to enhance its profitability and risk resilience by extending its industrial chain and optimizing its product structure in the chemical new materials sector [5] - The company recognizes that breakthroughs in processing technology for UPE products are essential for meeting future market demands [6] Industry Expectations - There is a consensus among downstream enterprises that while domestic UPE has rapidly developed in mid-to-low-end applications, there is still a performance gap in high-end applications such as medical and robotics [7] - Downstream companies express hope that Chengzhi's products will match or exceed the performance of foreign brands, particularly in terms of consistency and stability [7]

Meeting Details - The first extraordinary general meeting of shareholders for 2025 was held on December 29, 2025, at 14:00, with both on-site and online voting options available [2] - A total of 132 shareholders attended the meeting, representing 592,358,310 shares, which is 48.7442% of the total voting shares [2] Voting Participation - Among the attendees, 1 shareholder participated in on-site voting, representing 374,650,564 shares (30.8294% of total voting shares) [3] - 131 shareholders participated via online voting, representing 217,707,746 shares (17.9148% of total voting shares) [4] - 130 minority shareholders participated, representing 26,030,107 shares (2.1420% of total voting shares) [5] Resolutions Passed - The meeting approved several resolutions, including amendments to the company's articles of association and rules for shareholder meetings, with significant support from shareholders [10][12][14][17] - Resolution 1.01 regarding the amendment of the articles of association received 586,317,210 votes in favor (98.9802%) [10] - Resolution 1.02 regarding the amendment of the rules for shareholder meetings received 571,760,363 votes in favor (96.5227%) [12] - Resolution 1.03 regarding the amendment of the rules for board meetings received 568,072,303 votes in favor (95.9001%) [14] - Resolution 1.04 regarding the amendment of the cumulative voting system received 568,073,903 votes in favor (95.9004%) [16] - Resolution 1.05 regarding the amendment of the independent director system received 571,749,063 votes in favor (96.5208%) [17] Legal Opinion - The legal opinion provided by Beijing Zhongguang Law Firm confirmed that the meeting's procedures complied with relevant laws and regulations, and the voting results were valid [19] Election of Employee Representative Director - The company held a meeting on December 29, 2025, to elect Li Jing as the employee representative director, who will serve on the eighth board of directors [21] - Li Jing meets the qualifications required for the position and her election complies with legal requirements [21][23]

Group 1 - The company announced the convening of its first employee representative meeting on December 29, 2025 [1] - Li Jing was elected as the employee representative director for the company's eighth board of directors [1] - The term of the newly elected director will be consistent with the current board of directors [1]

Core Viewpoint - Chengzhi Co., Ltd. announced the convening of its first extraordinary general meeting of shareholders on December 29, 2025, to review multiple proposals, including the amendment of the company's articles of association [2] Group 1 - The extraordinary general meeting is scheduled for December 29, 2025 [2] - The agenda includes the proposal to amend the company's articles of association [2]

2025 年 12 月 30 日 诚志股份有限公司（以下简称"公司"）根据《公司法》及经公司 2025 年第 一次临时股东大会审议通过的《诚志股份有限公司章程》、《诚志股份有限公司董 事会议事规则》的有关规定，公司于 2025 年 12 月 29 日召开了 2025 年第一次职 工代表大会，选举李静女士（简历附后）为公司第八届董事会的职工代表董事， 与公司现任董事共同组成公司第八届董事会，其任期与本届董事会一致。 李静女士具备担任公司董事的任职资格和条件，其当选职工代表董事后，公 司第八届董事会中兼任公司高级管理人员以及由职工代表担任的董事人数总计 未超过公司董事总数的二分之一，符合相关法律法规和规范性文件的要求。 特此公告。 诚志股份有限公司 董事会 证券代码：000990 证券简称：诚志股份 公告编号：2025-046 诚志股份有限公司 关于选举职工代表董事的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 附：李静女士简历 李静女士，1981 年 4 月生,中国国籍,硕士研究生学历,曾任清控资产管理有 限公司总裁助理、董事会秘书、人事行政总监、党支部 ...

证券代码：000990 证券简称：诚志股份 公告编号：2025-045 诚志股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要提示： 1、本次股东大会未出现否决议案的情况； 2、本次股东大会不涉及变更前次股东大会决议的情况。 一、会议召开和出席情况 网络投票时间： （1）通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 12 月 29 日 9:15-9:25，9:30-11:30 和 13:00-15:00； 1、会议时间： 现场会议召开时间：2025 年 12 月 29 日 14:00 时； （2）通过深圳证券交易所互联网投票的具体时间为：2025年12月29日9:15 至 15:00 期间的任意时间； 2、现场会议召开地点：北京市清华科技园创新大厦 B 座 17 楼会议室； 3、召开方式：采取现场投票与网络投票相结合的方式； 4、召集人：公司董事会； 5、主持人：公司董事长龙大伟先生； （一）会议召开情况 1、股东出席的总体情况 通过现场和网络投票的股东 132 人，代表股份 592, ...